Saturday, January 24, 2015 10:21:42 PM
See rule 2110.
[url][/url][tag]http://finra.complinet.com/en/display/display_viewall.html?rbid=2403&element_id=9859&print=1[/tag]
A pattern or practice of late reporting without exceptional circumstances may be considered conduct inconsistent with high standards of commercial honor and just and equitable principles of trade, in violation of Rule 2110.
These ”Off Market” trades are typically used by larger investors to trade larger lots at pre-arranged prices without risk of driving the price upward or downward.
It could be foreign transactions too....but given that this is at a price slightly higher than the low of day, and not near the volume during market hours...it smells of short covering.
It could very well be that it is indeed a prearranged price point agreed to by an MM and investor. MM's don't mind doing it and given that they don't make a lot of money.....they can make some money on legit transactions by shorting after buying shares during regular market hours and selling to someone accumulating in a t trade transaction. I have seen this as a fairly common practice for NASDAQ stocks. It does have to stand up to scrutiny, but how much scrutiny is anyones guess. Lets watch and see if it continues.
It almost always indicates increased interest in a stock. MM's make money in fees, accumulating for someone AND they also make some money shorting. It is anyones guess as the waters are pretty muddy. Either way, you would have to contact an MM to do this for you, and be willing to pay their fees. I don't think they are making a whole lot of money. But they do have their ways.
Recent KBLB News
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 11/22/2023 09:31:54 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 11/16/2023 09:30:34 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 09:43:51 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 09/11/2023 08:30:50 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 09/08/2023 04:15:15 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 09/01/2023 08:30:52 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 08:35:05 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM